X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (134203) 134203
Newspaper Article (3592) 3592
Newsletter (3305) 3305
Book Chapter (778) 778
Magazine Article (694) 694
Transcript (253) 253
Book / eBook (191) 191
Web Resource (128) 128
Conference Proceeding (74) 74
Dissertation (69) 69
Streaming Video (41) 41
Trade Publication Article (40) 40
Publication (29) 29
Book Review (27) 27
Government Document (22) 22
Reference (20) 20
Report (9) 9
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (101827) 101827
female (46289) 46289
antibodies, monoclonal - therapeutic use (41730) 41730
animals (40894) 40894
male (38225) 38225
middle aged (26890) 26890
oncology (24346) 24346
adult (23831) 23831
monoclonal antibodies (23318) 23318
mice (22356) 22356
immunology (20859) 20859
antibodies (20825) 20825
aged (19050) 19050
treatment outcome (18708) 18708
cancer (17554) 17554
monoclonal-antibody (13409) 13409
antibodies, monoclonal, humanized (12740) 12740
immunotherapy (12722) 12722
proteins (12554) 12554
therapy (12219) 12219
care and treatment (11967) 11967
research (11925) 11925
antibodies, monoclonal, humanized - therapeutic use (11360) 11360
antineoplastic agents - therapeutic use (11266) 11266
pharmacology & pharmacy (11027) 11027
health aspects (10653) 10653
rituximab (10443) 10443
expression (10161) 10161
analysis (10062) 10062
antineoplastic combined chemotherapy protocols - therapeutic use (9451) 9451
medicine, research & experimental (9224) 9224
chemotherapy (9110) 9110
antibodies, monoclonal - administration & dosage (9036) 9036
hematology (8888) 8888
infliximab (8656) 8656
antibodies, monoclonal - adverse effects (8597) 8597
antigens (7890) 7890
tumors (7781) 7781
antibodies, monoclonal - immunology (7712) 7712
immunoglobulins (7439) 7439
drug therapy (7387) 7387
medicine & public health (7361) 7361
monoclonal-antibodies (7253) 7253
viral antibodies (7191) 7191
rheumatology (6994) 6994
bevacizumab (6958) 6958
clinical trials (6665) 6665
aged, 80 and over (6606) 6606
antibody (6499) 6499
research article (6486) 6486
medical research (6425) 6425
medicine (6383) 6383
antibodies, monoclonal - pharmacology (6333) 6333
transplantation (6218) 6218
patients (6195) 6195
immunosuppressive agents - therapeutic use (6138) 6138
adolescent (5978) 5978
cell line, tumor (5949) 5949
multidisciplinary sciences (5903) 5903
disease (5900) 5900
prognosis (5887) 5887
vaccines (5869) 5869
double-blind (5865) 5865
surgery (5813) 5813
retrospective studies (5800) 5800
cell biology (5563) 5563
mice, inbred balb c (5538) 5538
biotechnology & applied microbiology (5448) 5448
inflammation (5443) 5443
apoptosis (5442) 5442
efficacy (5394) 5394
clinical trials as topic (5369) 5369
cytokines (5305) 5305
cells (5265) 5265
abridged index medicus (5219) 5219
lymphocytes (5173) 5173
time factors (5163) 5163
tumor necrosis factor-alpha - antagonists & inhibitors (5115) 5115
biochemistry & molecular biology (5111) 5111
disease models, animal (5101) 5101
metastasis (5100) 5100
young adult (5097) 5097
immunohistochemistry (5039) 5039
safety (4958) 4958
enzyme-linked immunosorbent assay (4883) 4883
studies (4866) 4866
antirheumatic agents - therapeutic use (4821) 4821
risk factors (4761) 4761
trastuzumab (4639) 4639
flow cytometry (4592) 4592
gene expression (4581) 4581
rats (4538) 4538
rheumatoid arthritis (4489) 4489
t cells (4486) 4486
breast cancer (4445) 4445
antibodies, monoclonal, murine-derived (4379) 4379
follow-up studies (4375) 4375
biological products (4321) 4321
infections (4319) 4319
physiological aspects (4295) 4295
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (115) 115
Gerstein Science - Stacks (93) 93
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Engineering & Comp. Sci. - Stacks (4) 4
UofT at Mississauga - Stacks (4) 4
Gerstein Science - Closed Orders (1) 1
Gerstein Science - Missing (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (138238) 138238
Japanese (1584) 1584
French (1256) 1256
German (1156) 1156
Spanish (605) 605
Chinese (482) 482
Russian (200) 200
Italian (191) 191
Polish (144) 144
Hungarian (119) 119
Danish (104) 104
Dutch (93) 93
Czech (90) 90
Portuguese (71) 71
Korean (39) 39
Swedish (36) 36
Finnish (35) 35
Norwegian (30) 30
Hebrew (29) 29
Croatian (25) 25
Romanian (20) 20
Serbian (9) 9
Turkish (8) 8
Ukrainian (7) 7
Slovak (6) 6
Arabic (4) 4
Lithuanian (4) 4
Bulgarian (3) 3
Icelandic (3) 3
Bosnian (2) 2
Slovenian (2) 2
Ndonga (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 1. Aufl., ISBN 0470117915, xv, 889
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies... 
Monoclonal antibodies | Antibodies, Monoclonal | Drug Discovery | Therapeutic use | Immunotherapy
Book
mAbs, ISSN 1942-0870, 2015, Volume 7, Issue 1, pp. 9 - 14
Since the commercialization of the first therapeutic monoclonal antibody product in 1986, this class of biopharmaceutical products has grown significantly so that, as of November 10, 2014, forty-seven... 
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | RECOMBINANT PROTEIN THERAPEUTICS | SUCCESS RATES | CULTURE PROCESS-DEVELOPMENT | DRUG DEVELOPMENT | TRENDS | United States | Europe | Humans | Antibodies, Monoclonal - therapeutic use | Drug Approval | Antibodies, Monoclonal - economics | Marketing
Journal Article
Nature (London), ISSN 1476-4687, 2013, Volume 503, Issue 7475, pp. 224 - 228
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | DENILEUKIN DIFTITOX | NON-HODGKINS-LYMPHOMAS | FOLLOW-UP | BRENTUXIMAB VEDOTIN SGN-35 | OPEN-LABEL | ALLOGENEIC TRANSPLANTATION | SINGLE-AGENT | PHASE-II TRIAL | ONCOLOGY | SALVAGE THERAPY | HIGH-DOSE CHEMOTHERAPY | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 8, pp. 745 - 755
.... This placebo-controlled study investigated the effects of denosumab, a fully human monoclonal antibody against the receptor activator of nuclear factor-κ... 
ZOLEDRONIC ACID | FRACTURE | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Immunological reviews, ISSN 0105-2896, 2016, Volume 270, Issue 1, pp. 95 - 112
...). Together, this triggered the development of various therapeutic CD38 antibodies, including daratumumab, isatuximab, and MOR202... 
isatuximab | therapeutic antibody | CD38 | multiple myeloma | cancer | daratumumab | Isatuximab | Therapeutic antibody | Daratumumab | Multiple myeloma | Cancer | CYCLIC ADP-RIBOSE | AUTOREACTIVE PLASMA-CELLS | BONE-MARROW | LENALIDOMIDE PLUS DEXAMETHASONE | IMMUNOLOGY | ANTITUMOR-ACTIVITY | MULTIPLE-MYELOMA CELLS | HIGH-DOSE DEXAMETHASONE | INTERGROUPE FRANCOPHONE | RETINOIC ACID | THERAPEUTIC ACTIVITY | Immunomodulation - drug effects | Recurrence | Humans | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | ADP-ribosyl Cyclase 1 - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - pharmacology | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Drug Evaluation, Preclinical | Hematologic Neoplasms - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | ADP-ribosyl Cyclase 1 - genetics | Antibodies, Monoclonal - pharmacology | Treatment Outcome | Clinical Studies as Topic | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hematologic Neoplasms - drug therapy | Protein Binding | ADP-ribosyl Cyclase 1 - metabolism | Hematologic Neoplasms - genetics | Hematologic Neoplasms - immunology | Cytotoxicity, Immunologic | Enzymes | Analysis | Therapeutics | Monoclonal antibodies | Homeopathy | Materia medica and therapeutics | Index Medicus | Invited Reviews | Invited Review
Journal Article